IN2013MU03918A - - Google Patents

Download PDF

Info

Publication number
IN2013MU03918A
IN2013MU03918A IN3918MU2013A IN2013MU03918A IN 2013MU03918 A IN2013MU03918 A IN 2013MU03918A IN 3918MU2013 A IN3918MU2013 A IN 3918MU2013A IN 2013MU03918 A IN2013MU03918 A IN 2013MU03918A
Authority
IN
India
Prior art keywords
abstract
pharmaceutical compositions
relates
present
anticancer drugs
Prior art date
Application number
Other languages
English (en)
Inventor
Darshana Jain
Amrita Bajaj
Geena Malhotra
Preeti Raut
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Priority to PCT/GB2014/053684 priority Critical patent/WO2015087083A1/en
Priority to IN3918MU2013 priority patent/IN2013MU03918A/en
Publication of IN2013MU03918A publication Critical patent/IN2013MU03918A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN3918MU2013 2013-12-13 2014-12-12 IN2013MU03918A (da)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/GB2014/053684 WO2015087083A1 (en) 2013-12-13 2014-12-12 Intranasal pharmaceutical compositions of polymeric nanoparticles
IN3918MU2013 IN2013MU03918A (da) 2013-12-13 2014-12-12

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3918MU2013 IN2013MU03918A (da) 2013-12-13 2014-12-12

Publications (1)

Publication Number Publication Date
IN2013MU03918A true IN2013MU03918A (da) 2015-09-25

Family

ID=52282753

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3918MU2013 IN2013MU03918A (da) 2013-12-13 2014-12-12

Country Status (2)

Country Link
IN (1) IN2013MU03918A (da)
WO (1) WO2015087083A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201800002402A1 (it) * 2018-02-05 2019-08-05 Univ Degli Studi Roma La Sapienza Composto per uso nel trattamento di patologie cerebrali
CN109364029A (zh) * 2018-12-04 2019-02-22 临沂大学 一种白藜芦醇微球及其制备方法
CN110327302A (zh) * 2019-07-23 2019-10-15 大连工业大学 一种增强越橘花色苷稳定性的壳聚糖-果胶复合体系的制备方法及其应用
US20220370372A1 (en) * 2019-09-27 2022-11-24 Greenmark Biomedical Inc. Bisphosphonate loaded starch nanoparticle
CN111388406B (zh) * 2020-03-24 2024-02-23 西安力邦医药科技有限责任公司 氟维司群或其衍生物可注射递药贮库及其制备方法和应用
CN112390876B (zh) * 2020-11-30 2022-09-27 广西冠峰生物制品有限公司 一种降低人血白蛋白货架期铝离子释放的方法
CN113512236A (zh) * 2021-05-24 2021-10-19 广州市尚信净化工程有限公司 一种氧化刺槐豆胶-卡拉胶微球及其制备方法
CN115040689B (zh) * 2022-05-11 2023-02-10 上海摩漾生物科技有限公司 一种高流动性羟基磷灰石纳米材料及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1815851A1 (en) * 2006-02-03 2007-08-08 NanoDel Technologies GmbH Nanoparticles designed for drug delivery
US20110064664A1 (en) * 2007-10-08 2011-03-17 The Board Of Regents Of The University Of Texas System Methods and compositions involving chitosan nanoparticles
WO2009108932A2 (en) * 2008-02-28 2009-09-03 The Johns Hopkins University Selectin ligands useful in the diagnosis and treatment of cancer
CN102159247A (zh) * 2008-07-30 2011-08-17 日东电工株式会社 药物载体
WO2010059963A2 (en) * 2008-11-21 2010-05-27 The Board Of Regents Of The University Of Texas System Preparation and methodology of silk fibroin nanoparticles
US20120277158A1 (en) * 2009-10-06 2012-11-01 Angiochem Inc. Compositions and methods for the transport of therapeutic agents
CA2820236C (en) * 2012-06-15 2022-07-19 The Royal Institution For The Advancement Of Learning/Mcgill University Non-viral nanoparticle-based delivery system

Also Published As

Publication number Publication date
WO2015087083A1 (en) 2015-06-18

Similar Documents

Publication Publication Date Title
IL288961A (en) Pharmaceutical preparations
IN2013MU03918A (da)
PL2943181T3 (pl) Kompozycje farmaceutyczne
ZA201602447B (en) Improved pharmaceutical compositions of pimobendan
PL3043778T3 (pl) Kompozycje farmaceutyczne zawierające refametinib
EP4005604C0 (en) ADMINISTRATION OF MEDICINES
IL237139A0 (en) Pharmaceutical compositions of memantine
PT2827858T (pt) Administração de um agente antitumoral
IN2013MU03641A (da)
PL2887924T3 (pl) Kompozycje farmaceutyczne etorykoksybu
PL2991618T3 (pl) Stabilna kompozycja farmaceutyczna o wysokim stężeniu lewoleukoworyny
AU2014271207A1 (en) Targeted delivery of drugs to the myometrium
EP2999461A4 (en) Targeted delivery of drugs to the myometrium
HK1223018A1 (zh) 類胡蘿蔔素的醫藥組合物
HRP20171888T1 (hr) Farmaceutski pripravci
IN2013MU02469A (da)
IN2013MU03801A (da)
GB201603522D0 (en) Pyrazolochalcones as potential anticancer agents
GB201319437D0 (en) Delivery of drugs
EP2884963A4 (en) STABLE PHARMACEUTICAL FORMULATION OF CABAZITAXEL
GB201304699D0 (en) Pharmaceutical compositions
IN2013CH05770A (da)
AU2013901842A0 (en) Targeted delivery of drugs to the myometrium
GB201321497D0 (en) Pharmaceutical compositions
IN2013MU02715A (da)